Matrix: Saliva

As autoimmune thyroid testing grows, QC manufacturers face an increasing challenge to secure anti-TPO materials that combine reliable performance with consistent, long-term supply. Native anti-TPO serum and plasma provide excellent clinical relevance, but high-titre material can be difficult to source. Engineered Human Fc anti-TPO antibodies offer an alternative route to greater consistency and scalable supply.